#breast cancer — Saturday, August 22, 2026 (1 items)
| 0 | ℹ |
Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial.
(nature.com)
|
Nature Communications 2026-08-22 | #breast cancer #her2 #neoadjuvant #biomarker #immunotherapy |